Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (JNJ). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Johnson & Johnson Issues FY 2013 EPS Guidance Below Analysts' Estimates
Johnson & Johnson announced that for fiscal 2013, it expects earnings per share in the range of $5.35 to $5.45, which excludes the impact of special items. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $5.49 for fiscal 2013.
Latest Key Developments in Pharmaceuticals
- H Lundbeck A/S Announces Positive Results from Pre-Clinical Studies with Vortioxetine
- Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Announces Changes of General Manager
- Merck & Co Inc Announces $5 Billion Accelerated Share Repurchase
- Herbalife Ltd Engages PricewaterhouseCoopers LLP As Auditors
- Share this
- Link this
- Digg this
Follow Reuters